strive tirzepatide/glycine/b12 Tirzepatide in SubMagna® Tirzepatide/Glycine/B12 2 ml | Coded
Description
Future RCTs should move beyond weight reduction as the primary endpoint and incorporate disease-relevant outcomes such as lower-limb volume assessed by magnetic resonance imaging, quantification of fibrotic tissue through histological or imaging biomarkers, and objective evaluation of inflammation using circulating cytokines or tissue-based markers

While thats promising, more detailed research is still underway to better understand how well it works as a standalone treatment

Weight Loss Significant weight reduction observed in clinical trials
Where Mounjaro is used during breastfeeding, a few practical points are worth keeping in mind so that both your diabetes and your baby's needs are well managed

After confirming that the new dose is tolerable (usually by the second week), you can return to your preferred evening or bedtime timing

The curve was still descending: Participants on retatrutide hadn't plateaued at week 48, suggesting final Phase 3 numbers could be higheror that the comparison gap might narrow once both drugs reach equilibrium
